SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nuveen Asset Management, LLC | 111,774 | $422,506 | 0.00% |
| CREDIT SUISSE AG/ | 33,279 | $125,795 | 0.00% |
| CITIGROUP INC | 1,767 | $6,679 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 32,250 | $121,905 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 12,940 | $48,913 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 324,403 | $1,226,243 | 0.00% |
| GOLDMAN SACHS GROUP INC | 239,448 | $905,113 | 0.00% |
| MORGAN STANLEY | 84,213 | $318,326 | 0.00% |
| Invesco Ltd. | 12,857 | $48,600 | 0.00% |
| AMALGAMATED BANK | 2,650 | $10 | 0.00% |
| WOLVERINE TRADING, LLC | 20,000 | $75,600 | 0.00% |
| BANK OF MONTREAL /CAN/ | 13,835 | $97,537 | 0.00% |
| BlackRock Inc. | 2,566,784 | $9,702,445 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,761 | $21,777 | 0.00% |
| Bank of New York Mellon Corp | 83,924 | $317,232 | 0.00% |
| Citadel Advisors | 49,100 | $185,598 | 0.00% |
| Citadel Advisors | 115,600 | $436,968 | 0.00% |
| Citadel Advisors | 11,538 | $43,614 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 113,300 | $428,274 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 238,500 | $901,530 | 0.00% |
External links
This page lists SILVERBACK THERAPEUTICS INC's shareholders in Q3 2023. To view SILVERBACK THERAPEUTICS INC's shareholder history, click here.